Smith & Nephew (SN) Competitors GBX 1,120.50 +2.50 (+0.22%) As of 06/11/2025 Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendHeadlinesInsider TradesSustainabilityBuy This Stock SN vs. HLN, SGE, WHR, ANP, CLX, TPX, PNPL, LEG, ULVR, and NIOXShould you be buying Smith & Nephew stock or one of its competitors? The main competitors of Smith & Nephew include Haleon (HLN), The Sage Group (SGE), Warehouse REIT (WHR), Anpario (ANP), Calnex Solutions (CLX), TPXimpact (TPX), Pineapple Power (PNPL), Legendary Investments (LEG), Unilever (ULVR), and NIOX Group (NIOX). Smith & Nephew vs. Its Competitors Haleon The Sage Group Warehouse REIT Anpario Calnex Solutions TPXimpact Pineapple Power Legendary Investments Unilever NIOX Group Smith & Nephew (LON:SN) and Haleon (LON:HLN) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation. Is SN or HLN more profitable? Haleon has a net margin of 9.66% compared to Smith & Nephew's net margin of 5.41%. Haleon's return on equity of 6.54% beat Smith & Nephew's return on equity.Company Net Margins Return on Equity Return on Assets Smith & Nephew5.41% 5.85% 4.51% Haleon 9.66%6.54%4.45% Do insiders & institutionals have more ownership in SN or HLN? 62.2% of Smith & Nephew shares are owned by institutional investors. Comparatively, 43.9% of Haleon shares are owned by institutional investors. 0.2% of Smith & Nephew shares are owned by insiders. Comparatively, 10.7% of Haleon shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community favor SN or HLN? Smith & Nephew received 548 more outperform votes than Haleon when rated by MarketBeat users. Likewise, 62.02% of users gave Smith & Nephew an outperform vote while only 31.58% of users gave Haleon an outperform vote. CompanyUnderperformOutperformSmith & NephewOutperform Votes56062.02% Underperform Votes34337.98% HaleonOutperform Votes1231.58% Underperform Votes2668.42% Is SN or HLN a better dividend stock? Smith & Nephew pays an annual dividend of GBX 29 per share and has a dividend yield of 2.6%. Haleon pays an annual dividend of GBX 6 per share and has a dividend yield of 1.5%. Smith & Nephew pays out 104.4% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Haleon pays out 50.5% of its earnings in the form of a dividend. Which has higher valuation & earnings, SN or HLN? Haleon has higher revenue and earnings than Smith & Nephew. Haleon is trading at a lower price-to-earnings ratio than Smith & Nephew, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSmith & Nephew£7.08B1.73£382.79M£27.7740.34Haleon£11.07B3.26£1.07B£11.8933.66 Which has more risk and volatility, SN or HLN? Smith & Nephew has a beta of 0.62, indicating that its share price is 38% less volatile than the S&P 500. Comparatively, Haleon has a beta of 0.19, indicating that its share price is 81% less volatile than the S&P 500. Does the media prefer SN or HLN? In the previous week, Smith & Nephew and Smith & Nephew both had 1 articles in the media. Smith & Nephew's average media sentiment score of 1.16 beat Haleon's score of 0.00 indicating that Smith & Nephew is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Smith & Nephew 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Haleon 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts recommend SN or HLN? Smith & Nephew currently has a consensus target price of GBX 7,840, indicating a potential upside of 599.69%. Haleon has a consensus target price of GBX 457, indicating a potential upside of 14.19%. Given Smith & Nephew's higher possible upside, analysts clearly believe Smith & Nephew is more favorable than Haleon.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Smith & Nephew 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00Haleon 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummarySmith & Nephew beats Haleon on 11 of the 18 factors compared between the two stocks. Get Smith & Nephew News Delivered to You Automatically Sign up to receive the latest news and ratings for SN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SN vs. The Competition Export to ExcelMetricSmith & NephewMedical Devices IndustryMedical SectorLON ExchangeMarket Cap£12.28B£3.30B£5.60B£2.93BDividend Yield3.66%2.44%5.28%4.90%P/E Ratio40.3473.4227.23123.18Price / Sales1.73112.47417.65243,308.49Price / Cash18.6815.9938.2528.07Price / Book1.883.817.124.75Net Income£382.79M£126.02M£3.23B£5.91B7 Day Performance3.51%1.35%2.74%6.94%1 Month Performance4.82%9.78%8.94%16.69%1 Year Performance11.11%-0.49%31.59%77.68% Smith & Nephew Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SNSmith & Nephew4.0326 of 5 starsGBX 1,120.50+0.2%GBX 7,840+599.7%+8.9%£12.28B£7.08B40.3418,452News CoveragePositive NewsHigh Trading VolumeHLNHaleon1.3001 of 5 starsGBX 414.70+0.1%GBX 457+10.2%+24.4%£37.43B£11.07B34.8825,408High Trading VolumeSGEThe Sage Group2.2178 of 5 starsGBX 1,232.50+1.1%GBX 3,446.67+179.6%+21.6%£12.20B£2.14B47.9111,326Dividend IncreaseWHRWarehouse REIT1.8923 of 5 starsGBX 106.20+0.2%GBX 108+1.7%+32.8%£449.88M£50.81M1.0361,000News CoverageEarnings ReportANPAnparioN/AGBX 436.26-2.0%GBX 435-0.3%+42.0%£74.43M£33.50M24.09109CLXCalnex Solutions3.2632 of 5 starsGBX 54.26-1.3%GBX 115+111.9%+7.0%£48.22M£16.52M1,200.459,000News CoverageInsider TradeGap UpTPXTPXimpactN/AGBX 23.30+3.6%N/A-50.6%£21.15M£84.64M-1.0312,000Gap UpPNPLPineapple PowerN/AN/AN/AN/A£2.28MN/A-274.002High Trading VolumeLEGLegendary InvestmentsN/AN/AN/AN/A£0.00N/A0.0019,900Gap DownULVRUnilever0.6726 of 5 starsGBX 4,652+0.0%GBX 4,000-14.0%+6.4%£137.38B£70.72B21.04148,000High Trading VolumeNIOXNIOX GroupN/AGBX 69+1.2%GBX 90+30.4%+0.0%£28.34B£3.53B2,847.5192 Related Companies and Tools Related Companies Haleon Competitors The Sage Group Competitors Warehouse REIT Competitors Anpario Competitors Calnex Solutions Competitors TPXimpact Competitors Pineapple Power Competitors Legendary Investments Competitors Unilever Competitors NIOX Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:SN) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBanks aren’t ready for this altcoin—are you?While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly po...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Smith & Nephew plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Smith & Nephew With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.